Patients with mutations in PFN1 display atrophy of the limbs and it has been suggested that PFN1 contributes to ALS pathogenesis by altering actin dynamics resulting in axon outgrowth inhibition [189]. Here, PFN1 is linked to amyotrophic lateral sclerosis.